Inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H activity

Biology

Volumn 1, Issue 3, 2012, Pages 521-541

  Ilina, Tatiana ^a   LaBarge, Krystal ^a   Sarafianos, Stefan G ^b   Ishima, Rieko ^a   Parniak, Michael A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Missouri   (United States)

Author keywords

HIV 1; Reverse transcription; Ribonuclease H (RNase H); Ribonuclease H inhibitor (RNHI)

Indexed keywords

EID: 84885680134     PISSN: None     EISSN: 20797737     Source Type: Journal    
DOI: 10.3390/biology1030521     Document Type: Review

References (60)

1. Ilina, T.; Parniak, M.A. Inhibitors of HIV-1 reverse transcriptase. Adv. Pharmacol. 2008, 56, 121-167.
2. Jochmans, D. Novel HIV-1 reverse transcriptase inhibitors. Virus Res. 2008, 134, 171-185.
3. Huang, H.; Chopra, R.; Verdine, G.L.; Harrison, S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 1998, 282, 1669-1675.
4. Sarafianos, S.G.; Das, K.; Tantillo, C.; Clark, A.D., Jr.; Ding, J.; Whitcomb, J.M.; Boyer, P.L.; Hughes, S.H.; Arnold, E. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 2001, 20, 1449-1461.
5. Sarafianos, S.G.; Marchand, B.; Das, K.; Himmel, D.H.; Parniak, M.A.; Hughes, S.H.; Arnold, E. Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanism of Polymerization Inhibition. J. Mol. Biol. 2009, 385, 693-713.
6. Pettersen, E.F.; Goddard, T.D.; Huang, C.C.; Couch, G.S.; Greenblatt, D.M.; Meng, E.C.; Ferrin, T.E. UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25, 1605-1612.
7. Davies, J.F.; Hostomska, Z.; Hostomsky, Z.; Jordan, S.R.; Matthews, D.A. Crystal Structure of the Ribonuclease H Domain of HIV-I Reverse Transcriptase. Science 1991, 252, 88-95.
8. Julias, J.G.; McWilliams, M.J.; Sarafianos, S.G.; Arnold, E.; Hughes, S.H. Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. Proc. Natl. Acad. Sci. USA 2002, 99, 9515-9520.
9. Julias, J.G.; McWilliams, M.J.; Sarafianos, S.G.; Alvord, W.G.; Arnold, E.; Hughes, S.H. Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity. J. Virol. 2003, 77, 8548-8554.
10. Rausch, J.W.; Lener, D.; Miller, J.T.; Julias, J.G.; Hughes, S.H.; Le Grice, S.F. Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity. Biochemistry 2002, 41, 4856-4865.
11. Arion, D.; Sluis-Cremer, N.; Min, K.L.; Abram, M.E.; Fletcher, R.S.; Parniak, M.A. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones. J. Biol. Chem. 2002, 277, 1370-1374.
12. McWilliams, M.J.; Julias, J.G.; Sarafianos, S.G.; Alvord, W.G.; Arnold, E.; Hughes, S.H. Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization. Virology 2006, 348, 378-388.
13. Champoux, J.J. Roles of ribonuclease H in reverse transcription. In Reverse Transcriptase; Skalka, A.M., Goff, S.P., Eds.; Cold Spring Harbor Press: New York, NY, USA, 1993; pp. 103-118.
14. Schultz, S.J.; Champoux, J.J. RNase H activity: Structure, specificity, and function in reverse transcription. Virus Res. 2008, 134, 86-103.
15. Kati, W.M.; Johnson, K.A.; Jerva, L.F.; Anderson, K.S. Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 1992, 267, 25988-25997.
16. DeStefano, J.J.; Mallaber, L.M.; Fay, P.J.; Bambara, R.A. Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase. Nucleic Acids Res. 1993, 21, 4330-4338.
17. Furfine, E.S.; Reardon, J.E. Reverse transcriptase. RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 1991, 266, 406-412.
18. Ilina, T.; Van Ry, A.; Nagy, E.; Parniak, M.A. Mutations in HIV-1 RT RNase H domain reducing RT-associated RNase H activity have no impact on resistance to the nucleoside RT inhibitors. Unpublished work, 2012.
19. Fletcher, R.S.; Syed, K.; Mithani, S.; Dmitrienko, G.I.; Parniak, M.A. Carboxanilide derivative nonnucleoside inhibitors of HIV-1 reverse transcriptase interact with different mechanistic forms of the enzyme. Biochemistry 1995, 34, 4036-4042.
20. Hazuda, D.J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J.A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M. D. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000, 287, 646-650.
21. Grobler, J.A.; Stillmock, K.; Hu, B.; Witmer, M.; Felock, P.; Espeseth, A.; Wolfe, A.; Egbertson, M.; Bourgeois, M.; Melamed, J.; Wai, J.S.; Young, S.; Vacca, J.; Hazuda, D. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc. Natl. Acad. Sci. USA 2002, 99, 6661-6666.
22. Shaw-Reid, C.A.; Munshi, V.; Graham, P.; Wolfe, A.; Witmer, M.; Danzeisen, R.; Olsen, D.B.; Carroll, S.S.; Embrey, M.; Wai, J.S.; Miller, M.D.; Cole, J.L.; Hazuda, D.J. Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid. J. Biol. Chem. 2003, 278, 2777-2780.
23. Parniak, M.A.; Min, K.L.; Budihas, S.R.; Le Grice, S.F.; Beutler, J.A. A fluorescence-based highthroughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity. Anal. Biochem. 2003, 322, 33-39.
24. Parniak, M.A.; Min, K.L. Substrate for assaying ribonuclease H activity. Patent, 6 March 2007. US7186520.
25. Parniak, M.A.; Min, K.L. Method of identifying or characterizing a compound that modulates ribonuclease H activity. US Patent 7,439,035, 21 October 2008.
26. Klumpp, K.; Mirzadegan, T. Recent progress in the design of small molecule inhibitors of HIV RNase H. Curr. Pharm. Drug 2006, 12, 1909-1922.
27. Yu, F.; Liu, X.; Zhan, P.; De Clercq, E. Recent advances in the research of HIV-1 RNase H inhibitors. Mini Rev. Med. Chem. 2008, 8, 1243-1251.
28. Tramontano, E.; Di Santo, R. HIV-1 RT-associated RNase H function inhibitors: Recent advances in drug development. Curr. Med. Chem. 2010, 17, 2837-53.
29. Tramontano, E.; Esposito, F.; Badas, R.; Di Santo, R.; Costi, R.; La Colla, P. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro. Antiv. Res. 2005, 65, 117-124.
30. Hazuda, D. J.; Anthony, N.J.; Gomez, R.P.; Jolly, S.M.; Wai, J.S.; Zhuang, L.; Fisher, T.E.; Embrey, M.; Guare, J.P., Jr.; Egbertson, M.S.; Vacca, J.P.; Huff, J.R.; Felock, P.J.; Witmer, M.V.; Stillmock, K.A.; Danovich, R.; Grobler, J.; Miller, M.D.; Espeseth, A.S.; Jin, L.; Chen, I.W.; Lin, J.H.; Kassahun, K.; Ellis, J.D.; Wong, B.K.; Xu, W.; Pearson, P.G.; Schleif, W.A.; Cortese, R.; Emini, E.; Summa, V.; Holloway, M.K.; Young, S.D. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase. Proc. Natl. Acad. Sci. USA 2004, 101, 11233-11238.
31. Su, H.P.; Yan, Y.; Prasad, S.; Smith, R.F.; Daniels, C.L.; Abeywickrema, P.D.; Reid, J.C.; Loughran, H.M.; Kornienko, M.; Sharma, S.; Grobler, J.A.; Xu, B.; Sardana, V.; Allison, T.J.; Williams, P.D.; Darke, P.L.; Hazuda, D.J.; Munshi, S. Structural Basis for the Inhibition of RNase H Activity of HIV-1 Reverse Transcriptase by RNase H Active Site-Directed Inhibitors. J. Virol. 2010, 84, 7625-7633.
32. Williams, P.D.; Staas, D.D.; Venkatraman, S.; Loughran, H.M.; Ruzek, R.D.; Booth, T.M.; Lyle, T.A.; Wai, J.S.; Vacca, J.P.; Feuston, B.P.; Ecto, L.T.; Flynn, J.A.; DiStefano, D.J.; Hazuda, D.J.; Bahnck, C.M.; Himmelberger, A.L.; Dornadula, G.; Hrin, R.C.; Stillmock, K.A.; Witmer, M.V.; Miller, M.D.; Grobler, J.A. Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold. Biooganic. Med. Chem. Lett. 2010, 20, 6754-6757.
33. Klumpp, K.; Hang, J.Q.; Rajendran, S.; Yang, Y.; Derosier, A.; Wong Kai In, P.; Overton, H.; Parkes, K.E.B.; Cammack, N.; Martin, J.A. Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors. Nucleic Acids Research 2003, 31, 6852-6859.
34. Hang, J.Q.; Rajendran, S.; Yang, Y.; Li, Y.; Wong Kai In, P.; Overton, H.; Parkes, K.E.B.; Cammack, N.; Martin, J.A.; Klumpp, K. Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides. Biochem. Biophys. Res. Comm. 2006, 317, 321-329.
35. Billamboz, M.; Bailly, F.; Barreca, M.L.; De Luca, L.; Mouscadet, J.F.; Calmels, C.; Andreola, M.L.; Witvrouw, M.; Christ, F.; Debyser, Z.; Cotelle, P. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain. J. Med. Chem. 2008, 51, 7717-7730.
36. Billamboz, M.; Bailly, F.; Lion, C.; Touati, N.; Vezin, H.; Calmels, C.; Androla, M.-L.; Christ, F.; Debyser, Z.; Cotelle, P. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: Discovery of a novel selective inhibitor of the ribonuclease H function. J. Med. Chem. 2011, 54, 1812-1824.
37. Budihas, S.R.; Gorshkova, I.; Gaidamakov, S.; Wamiru, A.; Bona, M.K.; Parniak, M.A.; Crouch, R.J.; McMahon, J.B.; Beutler, J.A.; Le Grice, S.F.J. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones. Nucleic Acids Res. 2005, 33, 1249-1256.
38. Himmel, D.M.; Meagley, K.A.; Pauly, T.A.; Bauman, J.D.; Das, K.; Dharia, C.; Clark, A.D., Jr.; Ryan, K.; Hickey, M.J.; Love, R.A.; Hughes, S.H.; Bergqvist, S.; Arnold, E. Structure of HIV-1 reverse transcriptase with the inhibitor β-thujaplicinol bound at the RNase H active site. Structure 2009, 17, 1625-1635.
39. Kirschberg, T.A.; Balakrishnan, M.; Squires, N.H.; Barnes, T.; Brendza, K.M.; Chen, X.; Eisenberg, E.J.; Jin, W.; Kutty, N.; Leavitt, S.; Liclican, A.; Liu, Q.; Liu X.; Mak, J.; Perry, J.K.; Wang, M.; Watkins, W.J.; Lansdon, E.B. RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: Design, biochemical activity, and structural information. J. Med. Chem. Lett. 2009, 52, 5781-5784.
40. Lansdon, E.B.; Liu, Q.; Leavitt, S.A.; Balakrishnan, M.; Perry, J.K.; Lancaster-Moyer, C.; Kutty, N.; Liu, X.; Squires, N.H.; Watkins, W.J.; Kirschberg, T.A. Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV RNase H inhibitors. Antimicrob. Agents Chemother. 2011, 55, 2905-2915.
41. Gerondelis, P.; Johns, B.A. The development of novel pyrido-pyrimidinone antiretrovirals with selective activity against HIV ribonuclease H. In Proceedings of Cold Spring Harbor Laboratories Conference on Retroviruses, Cold Spring Harbor, New York, NY, USA, 21-26 May 2012.
42. Johns, B.A.; Vethuisen, E.J. Therapeutic compounds. Patent, WO 2011/07547 A1, 23 June 2011.
43. Felts, A.K.; Labarge, K.; Bauman, J.D.; Patel, D.V.; Himmel, D.M.; Arnold, E.; Parniak, M.A.; Levy, R.M. Identification of alternative binding sites for inhibitors of HIV-1 ribonuclease H through comparative analysis of virtual enrichment studies. J. Chem. Inf. Model. 2011, 51, 1986-1998.
44. Archer, R.H.; Dykes, C.; Gerondelis, P.; Lloyd, A.; Fay, P.; Reichman, R.C.; Bambara, R.A.; Demeter, L.M. Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture. J. Virol. 2000, 74, 8390-8401.
45. Archer, R.H.; Wisniewski, M.; Bambara, R.A.; Demeter, L.M. The Y181C mutant of HIV-1 reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors alters the size distribution of RNase H cleavages. Biochemistry 2001, 40, 4087-4095.
46. Hang, J.Q.; Li, Y.; Yang, Y.; Cammack, N.; Mirzadegan, T.; Klumpp, K. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs). Biochem. Biophys. Res. Comm. 2007, 352, 341-350.
47. Di Grandi, M.; Olson, M.; Prashad, A.S.; Bebernitz, G.; Luckay, A.; Mullen, S.; Hu, Y.; Krishnamurthy, G.; Pitts, K.; O'Connell, J. Small molecule inhibitors of HIV RT Ribonuclease H. Bioorg. Med. Chem. Lett. 2010, 20, 398-402.
48. Ilina, T.; Van Ry, A.; Nagy, E.; Parniak, M.A. 1,2,4-Triazole Inhibitors of HIV-1 Reverse Transcriptase Ribonuclease H Activity. Unpublished work, 2012.
49. Kirschberg, T.A.; Balakrishnan, M.; Huang, W.; Hluhanich, R.; Kutty, N.; Liclican, A.C.; McColl, D.J.; Squires, N.H.; Lansdon, E.B. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase-structure-activity relationships and crystallographic analysis. Bioorg. Med. Chem. Lett. 2008, 18, 1131-1134.
50. Cichero, E.; Buffa, L.; Fossa, P. 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: Docking-based CoMFA and CoMSIA analyses. J. Mol. Model. 2011, 17, 1537-1550.
51. Borkow, G.; Fletcher, R.S.; Barnard, J.; Arion, D.; Motakis, D.; Dmitrienko, G.I.; Parniak, M.A. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone. Biochemistry 1997, 36, 3179-3185.
52. Himmel, D.M.; Sarafianos, S.G.; Dharmasena, S.; Hossain, M.M.; McCoy-Simandle, K.; Ilina, T.; Clark, A.D., Jr.; Knight, J.L.; Julias, J.G.; Clark, P.K.; Krogh-Jespersen, K.; Levy, R.M.; Hughes, S.H.; Parniak, M.A.; Arnold, E. HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site. ACS Chem. Biol. 2006, 1, 702-712.
53. Ilina, T.V.; Hossain, M.; Parniak, M.A. Mutations in the p51 thumb subdomain of HIV-1 reverse transcriptase (RT) provide resistance to acylhydrazone inhibitors of RT ribonuclease activity. In Proceedings of Cold Spring Harbor Laboratories Conference on Retroviruses, Cold Spring Harbor, New York, NY, USA, 19-24 May 2008.
54. Gong, Q.; Menon, L.; Ilina, T.; Miller, L.G.; Ahn, J.; Parniak, M.A.; Ishima, R. Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor. Chem. Biol. Drug Des. 2011, 77, 39-47.
55. Christen, M.T.; Menon, L.; Myshakina, N.S.; Ahn, J.; Parniak, M.A.; Ishima, R. Structural basis for the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain. Chem. Biol. Drug Des. 2012, doi:10.1111/cbdd.12010.
56. Wendeler, M.; Lee, H.-F.; Bermingham, A.; Miller, J.T.; Chertov, O.; Bona, M.K.; Baichoo, N.S.; Ehtesham, M.; Beutler, J.A.; O'Keefe, B.R.; Gotte, M.; Kvaratskhelia, M.; Le Grice, S.F.J. Vinylogous ureas as a novel class of reverse transcriptase-associated ribonuclease H activity. ACS Chem. Biol. 2008, 3, 635-644.
57. Chung, S.; Wendeler, M.; Rausch, J.W.; Beilhartz, G.; Gotte, M.; O'Keefe, B.R.; Bermingham, A.; Beutler, J.A.; Liu, S.; Zhuang, X.; Le Grice, S.F.J. Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H. Antimicrob. Agents Chemother. 2010, 54, 3913-3921.
58. Chung, S.; Miller, J.T.; Johnson, B.C.; Hughes, S.H.; Le Grice, S.F. Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J. Biol. Chem. 2012, 287, 4066-4075.
59. Nikolenko, G.N.; Palmer, S.; Maldarelli, F.; Mellors, J.W.; Coffin, J.M.; Pathak, V.K. Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc. Natl. Acad. Sci. USA 2005, 102, 2093-2098.
60. Ilina, T.V.; Parniak, M.A. Novel RNA/DNA Substrates for the Characterization of Ribonuclease H Activity. In Proceedings of 10th Annual Symposium on Antiviral Drug Resistance: Targets and Mechanisms, Richmond, VA, USA, 15-18 November 2009.